The Use of Intramuscular Cefoperazone versus Intramuscular Ceftriaxone in Patients with Nursing Home‐Acquired Pneumonia

199353 citationsJournal Article

Authors

Steven L. Phillips · United States Department of Veterans Affairs

Abstract

Intramuscular cefoperazone and intramuscular ceftriaxone are safe and effective in the treatment of nursing home-acquired pneumonia. The clinical outcomes in both treatment groups support their use within this select population without the need for transferring the patient to an acute care hospital. Clinical studies are needed to evaluate the impact of such therapy on the control of health care expenditures within the nursing home facility.

Topics & Keywords

Nosocomial Infections in ICU Pneumonia and Respiratory Infections Antibiotic Resistance in Bacteria

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the American Geriatrics Society

Volume 41, Issue 10, pp. 1071-1074

DOI: 10.1111/j.1532-5415.1993.tb06454.x

Field-Weighted Citation Impact: 2.61